Gestational age at birth and risk of gastric acid-related disorders in young adulthood

Casey Crump1, Marilyn A Winkleby, Jan Sundquist

  • 1Department of Medicine, Stanford University, CA, USA. kccrump@stanford.edu

Insights

Preterm birth is linked to higher risks of gastric acid issues in young adults. Lower gestational age at birth correlates with increased need for acid-reducing medications later in life.

Area of Science:

  • Gastroenterology
  • Perinatal Medicine
  • Epidemiology

Background:

  • Preterm birth is a known risk factor for infant gastric acid-related disorders.
  • Previous research has not extensively studied this association in young adulthood.

Purpose of the Study:

  • To investigate the long-term association between preterm birth and gastric acid-related disorders into young adulthood.
  • Utilize antisecretory medication data as a proxy for these disorders.

Main Methods:

  • National cohort study of 626,811 individuals born in Sweden (1973-1979).
  • Follow-up for antisecretory medication (PPI, H2RA) prescriptions from 2005-2009 (ages 25.5-37.0).
  • Exclusion of individuals with congenital anomalies and adjustment for comorbidities.

Main Results:

  • Inverse association found between gestational age at birth and antisecretory medication use in young adulthood.
  • Adjusted odds ratios for medication use increased with lower gestational age (e.g., 3.38 for 22-27 weeks vs. full-term).
  • Confounding by other comorbidities had minimal impact on the observed association.

Conclusions:

  • Low gestational age at birth is independently associated with an elevated risk of gastric acid-related disorders in young adulthood.
  • Findings highlight the importance of long-term monitoring for individuals born preterm.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Gastroesophageal Reflux Disease01:25

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...